Thiola EC 100 MG tablet 300S
Ended Awarded
- Contract number
- SPE2DB25FX7Y4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,087
Award facts
- Contract value 100% obligated
- $6,087.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 300 tablets of Thiola EC 100 mg with a ceiling value of $6,087.32. This firm fixed-price delivery order, issued on September 9, 2025, is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499.999 billion and extending through November 2026. The contract carries no set-aside designation, and the product will be performed at the contractor's location in Park Ridge, Illinois.
Thiola (tiopronin) is a pharmaceutical medication used in the treatment of cystinuria, a rare genetic disorder affecting amino acid metabolism. This delivery order reflects DMS Pharmaceutical Group's established role as a critical supplier in the federal pharmaceutical supply chain, delivering prescription medications and medical supplies to Department of Defense healthcare facilities nationwide. The company's extensive contract history demonstrates consistent success in providing branded and generic pharmaceutical products, biologics, and medical consumables to military health systems, with the underlying IDC enabling rapid procurement of diverse pharmaceutical items to support urgent medical supply needs across DoD facilities.
Quick answers
Who was awarded contract SPE2DB25FX7Y4?
SPE2DB25FX7Y4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FX7Y4 worth?
The government has obligated $6,087 on SPE2DB25FX7Y4.
Is contract SPE2DB25FX7Y4 an order under another contract?
Yes. SPE2DB25FX7Y4 is a delivery order under SPE2DB20D9354, an indefinite delivery contract.
Was contract SPE2DB25FX7Y4 competed?
The extent of competition for SPE2DB25FX7Y4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award